Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 426, doi. 10.1007/s11912-003-0030-x
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2003 AND VI 5 AND IP 5
Results: 17
1
2
Immunologic monitoring in chronic lymphocytic leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 419, doi. 10.1007/s11912-003-0029-3
- By:
- Publication type:
- Article
3
Immunologic monitoring in adults with acute lymphoblastic leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 413, doi. 10.1007/s11912-003-0028-4
- By:
- Publication type:
- Article
4
Monitoring of acute myeloid leukemia by flow cytometry.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 405, doi. 10.1007/s11912-003-0027-5
- By:
- Publication type:
- Article
5
Monitoring AML1-ETO and CBFΒ-MYH11 transcripts in acute myeloid leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 399, doi. 10.1007/s11912-003-0026-6
- By:
- Publication type:
- Article
6
Monitoring PML-RARα in acute promyelocytic leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 391, doi. 10.1007/s11912-003-0025-7
- By:
- Publication type:
- Article
7
Adaptive randomization in a treatment study of patients with adverse karyotype acute myeloid leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 390, doi. 10.1007/s11912-003-0024-8
- By:
- Publication type:
- Article
8
Early blast clearance by remission induction as a prognostic factor in acute myeloid leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 389, doi. 10.1007/s11912-003-0023-9
- By:
- Publication type:
- Article
9
Vaccination strategies for lymphomas.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 380, doi. 10.1007/s11912-003-0022-x
- By:
- Publication type:
- Article
10
Simian virus 40 and its association with human lymphomas.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 372, doi. 10.1007/s11912-003-0021-y
- By:
- Publication type:
- Article
11
New strategies in radioimmunotherapy for lymphoma.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 364, doi. 10.1007/s11912-003-0020-z
- By:
- Publication type:
- Article
12
Posttransplant lymphoproliferative disease: Pathogenesis, monitoring, and therapy.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 359, doi. 10.1007/s11912-003-0019-5
- By:
- Publication type:
- Article
13
Rituximab for lymphocyte-predominant Hodgkin’s disease.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 358, doi. 10.1007/s11912-003-0018-6
- By:
- Publication type:
- Article
14
Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 357, doi. 10.1007/s11912-003-0017-7
- By:
- Publication type:
- Article
15
Literature alert.
- Published in:
- 2003
- Publication type:
- Abstract
16
Web alert.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 349, doi. 10.1007/s11912-003-0015-9
- Publication type:
- Article
17
Randomized trials in oncology: A fertile ground for controversy.
- Published in:
- 2003
- By:
- Publication type:
- Editorial